MedPage Today18h
Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead
Pitted against more established balloon-expandable Sapien 3 valves in TAVR for severe aortic stenosis, the Myval devices ...
TCTMD1d
DETECT-AS: Alert System Increase AV Replacement in Eligible Patients
The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.
KTVF on MSN1d
Health Watch: 10 years of TAVR; The life-changing heart procedure keeping Alaskans strong
A decade after bringing Transcatheter Aortic Valve Replacement (TAVR) to Alaska, doctors at Providence Alaska Medical Center ...
MPR2d
Dapagliflozin Improves Outcomes in HF Patients After Valve Replacement
The DapaTAVI trial assessed the benefits of dapagliflozin in patients discharged after TAVI with a history of heart failure plus 1 of the following comorbidities: LVEF ≤40%, diabetes, or renal ...
AHA/ASA Journals2d
Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry
BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
Oxford Mail on MSN3d
Devices used to prevent stroke during heart procedure found to be ineffective
New research suggests cerebral embolic protection devices do not lower the risk of stroke in patients undergoing ...
New transcatheter valve safe, effective for treating aortic regurgitation
Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...
TCTMD5d
Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years
The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...